Quantinno Capital Management’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$485K Buy
81,295
+24,472
+43% +$116K ﹤0.01% 3172
2026
Q2
$252K Buy
56,823
+5,611
+11% +$24K ﹤0.01% 3257
2026
Q1
$224K Buy
51,212
+21,564
+73% +$102K ﹤0.01% 3169
2025
Q4
$150K Buy
+29,648
New +$138K ﹤0.01% 3097
2025
Q2
– Sell
-21,190
Closed -$85K – 2584
2025
Q1
$85K Buy
21,190
+6,970
+49% +$36.1K ﹤0.01% 2055
2024
Q4
$92.3K Buy
+14,220
New +$84.7K ﹤0.01% 1622

Other funds holding CTKB

Quantinno Capital Management's CTKB Position: Q3 2026 in Review

Quantinno Capital Management increased its Cytek Biosciences (CTKB) stake by 43% in Q3 2026, buying an estimated $116K and bringing the position to 81,295 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #3172.

Quantinno Capital Management first reported a position in CTKB in Q4 2024 and has held it in 6 quarters since. 150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • Quantinno Capital Management held 81,295 shares of Cytek Biosciences worth $485K as of Q3 2026.
  • Quantinno Capital Management bought 24,472 Cytek Biosciences shares in Q3 2026, an estimated $116K.
  • Cytek Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #3172 holding.
  • Quantinno Capital Management first reported a position in Cytek Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.